Angiotensin-converting enzyme I/D polymorphism is associated with COPD risk in Asian population: Evidence from a meta-Analysis

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 10, Issue 1, 2013, Pages 35-39

  Li, Wen ^a   Lan, Fen ^a   Yan, Fugui ^a   Shen, Huahao ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Angiotensin converting enzyme; COPD; Meta Analysis; Polymorphism

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; MOLECULAR MARKER;

ALLELE; ARTICLE; ASIAN; CHRONIC OBSTRUCTIVE LUNG DISEASE; ETHNICITY; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; META ANALYSIS; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CONFIDENCE INTERVALS; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENOTYPE; HUMANS; INDEL MUTATION; ODDS RATIO; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84874033413     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2012.727047     Document Type: Article

References (25)

1. Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997; 349:1269-1276.
2. Hanrahan JP, Sherman CB, Bresnitz EA, et al. Cigarette smoking and health. Am J Respir Crit Care Med 1996; 153: 861-865.
3. Erdos EG, Yang HY. An enzyme in microsomal fraction of kidney that inactivates bradykinin. Life Sci 1967; 6:569-574.
4. Cambien F, Alhenc-Gelas F, Herbeth B, et al. Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy study. Am J Hum Genet 1988; 43:774-780.
5. Costerousse O, Allegrini J, Lopez M, et al. Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J 1993; 290:33-40.
6. Zhang X, Wang C, Dai H, et al. Association between angiotensin-converting enzyme gene polymorphisms and exercise performance in patients with COPD. Respirology 2008; 13:683-688.
7. Ahsan A, Ram R, Baig MA, et al. ACE I allele and eNOS G allele crosstalk may have a role in chronic obstructive pulmonary disease. Clin Biochem 2004; 37:1037-1040.
8. Busquets X, MacFarlane NG, Heine-Suñer D, et al. Angiotensinconverting-enzyme gene polymorphisms, smoking and chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2007; 2:329-334.
9. Yildiz P, Oflaz H, Cine N, et al. Gene polymorphisms of endothelial nitric oxide synthase enzyme associated with pulmonary hypertension in patients with COPD. Respir Med 2003; 97:1282-1288.
10. Tkácová R, Joppa P, Stancák B, et al. The link between angiotensin-converting enzyme genotype and pulmonary artery pressure in patients with COPD. Wien Klin Wochenschr 2005; 117:210-214.
11. Gu H, Zhang H, Yang L. Relationships between polymorphisms of gene coding angiotensin converting enzyme and susceptibility to chronic obstructive pulmonary disease (in Chinese). Ji Chu Yi Xue Yu Lin Chuang 2003; 23: 174-177.
12. Jiang C, Zhang N. Angiotensin-converting enzyme I/D polymorphism in patients with chronic obstructive pulmonary disease and pneumocardial disease (in Chinese). Guo Wai Yi Xue 2004; 23: 248-249.
13. Pabst S, Theis B, Gillissen A, et al. Angiotensin-converting enzyme I/D polymorphism in chronic obstructive pulmonary disease. Eur J Med Res 2009;14 Suppl 4:177-181.
14. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-Analyses. BMJ 2003; 327:557-560.
15. Egger M, Davey Smith G, Schneider M, et al. Bias in meta analysis detected by a simple, graphical test. BMJ 1997; 315:629-634.
16. Kanazawa H, Okamoto T, Hirata K, et al. Deletion polymorphisms in the angiotensin converting enzyme gene are associated with pulmonary hypertension evoked by exercise challenge in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 162:1235-1238.
17. van Suylen RJ, Wouters EF, Pennings HJ, et al. The DD genotype of the angiotensin converting enzyme gene is negatively associated with right ventricular hypertrophy in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159:1791-1795.
18. de Beer VJ, de GraaffHJ, Hoekstra M, et al. Integrated control of pulmonary vascular tone by endothelin and angiotensin II in exercising swine depends on gender. Am J Physiol Heart Circ Physiol 2010; 298:1976-1985.
19. Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86:1343-1346.
20. Erdös EG. Angiotensin I converting enzyme and the changes in our concepts through the years. Lewis K. Dahl memorial lecture. Hypertension 1990; 16:363-370.
21. Zhang YM, Cao C, Liang K. Genetic polymorphism of epidermal growth factor 61AG and cancer risk: a metaanalysis. Cancer Epidemiol 2010; 34:150-156.
22. Zeidel A, Beilin B, Yardeni I, et al. Immune response in asymptomatic smokers. Acta Anaesthesiol Scand 2002; 46: 959-964.
23. Hopkinson NS, Li KW, Kehoe A, et al. Vitamin D receptor genotypes influence quadriceps strength in chronic obstructive pulmonary disease. Am J Clin Nutr 2008; 87: 385-390.
24. Hopkinson NS, Nickol AH, Payne J, et al. Angiotensin converting enzyme genotype and strength in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004;170:395-399.
25. Shrikrishna D, Astin R, Kemp PR, et al. Renin-Angiotensin system blockade: a novel therapeutic approach in chronic obstructive pulmonary disease. Clin Sci (Lond) 2012; 123: 487-498.